Advertisement

Experimental Design in Quantitative Proteomics

  • Tomasz BurzykowskiEmail author
  • Jürgen Claesen
  • Dirk Valkenborg
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1977)

Abstract

Metabolites and proteins are potential biomarkers. They can be identified with the help of mass spectrometry (MS). However, measurements obtained by using MS are prone to various random and systematic errors. The sensitivity of the technology to the errors poses practical challenges, including concerns about reproducibility of the MS-based assays and the possibility of false findings. Given the sensitivity, the proper design of MS-based experiments becomes of utmost importance. In this chapter, we review the basic experimental-design tools that can be used to prevent occurrence of errors that might cause misleading findings in MS-based experiments. We also present results of an experiment aimed at investigating variability of the intensity measurements produced by a MALDI-TOF mass spectrometer. The knowledge about the potential sources of systematic and random errors is fundamental in order to properly design an MS experiment.

Key words

Experimental design Quantitative proteomics Mass spectrometry Systematic error Random error 

References

  1. 1.
    Collins FS, Varmus H (2015) A new initiative on precision medicine. N Engl J Med 372:793–795CrossRefGoogle Scholar
  2. 2.
    Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89–95CrossRefGoogle Scholar
  3. 3.
    Quezada H, Guzmán-Ortiz AL, Díaz-Sánchez H et al (2017) Omics-based biomarkers: current status and potential use in the clinic. Bol Med Hosp Infant Mex 74:219–226PubMedGoogle Scholar
  4. 4.
    Buyse M, Sargent DJ, Grothey A et al (2010) Biomarkers and surrogate end points—the challenge of statistical validation. Nat Rev Clin Oncol 7:309–317CrossRefGoogle Scholar
  5. 5.
    Roychowdhury S, Chinnaiyan AM (2016) Translating cancer genomes and transcriptomes for precision oncology. CA Cancer J Clin 66:75–88CrossRefGoogle Scholar
  6. 6.
    Shehadeh LA, Hare JM (2013) Ribonucleic acid biomarkers for heart failure: is there a correlation between heart and blood transcriptomics? JACC Heart Fail 1:477–479CrossRefGoogle Scholar
  7. 7.
    Hathout Y (2015) Proteomic methods for biomarker discovery and validation. Are we there yet? Expert Rev of Proteomics 12:329–331CrossRefGoogle Scholar
  8. 8.
    Eidhammer I, Flikka K, Martens L, Mikalsen S-O (2007) Computational methods for mass spectrometry proteomics. John Wiley & Sons, ChichesterCrossRefGoogle Scholar
  9. 9.
    Datta S, Mertens BJA (eds) (2016) Statistical analysis of proteomics, metabolomics, and lipidomics data using mass spectrometry. Springer, New YorkGoogle Scholar
  10. 10.
    Hilario M, Kalousis A, Pellegrini C, Muller M (2006) Processing and classification of protein mass spectra. Mass Spectrom Rev 25:409–449CrossRefGoogle Scholar
  11. 11.
    Ejigu BA, Valkenborg D, Baggerman G et al (2013) Evaluation of normalization methods to pave the way towards large-scale LC-MS-based metabolomic profiling experiments. OMICS 17:473–485CrossRefGoogle Scholar
  12. 12.
    Petricoin EF III, Ardekani AM, Hitt BA et al (2002) Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359:572–577CrossRefGoogle Scholar
  13. 13.
    Conrads TP, Fusaro VA, Ross S et al (2004) High-resolution serum proteomic features for ovarian cancer detection. Endocr Relat Cancer 11:163–178CrossRefGoogle Scholar
  14. 14.
    Baggerly KA, Morris JS, Coombes KR (2004) Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics 20:777–785CrossRefGoogle Scholar
  15. 15.
    Gail MH (2005) Bias. In: Encyclopedia of biostatistics. Wiley, New YorkGoogle Scholar
  16. 16.
    Cox DR, Reid N (2000) The theory of the design of experiments. Chapman & Hall/CRC, Boca RatonGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Tomasz Burzykowski
    • 1
    Email author
  • Jürgen Claesen
    • 1
  • Dirk Valkenborg
    • 1
  1. 1.I-BioStatHasselt UniversityDiepenbeekBelgium

Personalised recommendations